A BILL 
To amend title XI of the Social Security Act to require 
that direct-to-consumer television advertisements for pre-
scription drugs and biological products include the list 
price of such drugs and products, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Drug Price Trans-
4
parency for Medicare Patients Act of 2019’’. 
5
22:38 Jun 20, 2019
H3327
2 
•HR 3327 IH
SEC. 2. REQUIREMENT THAT DIRECT-TO-CONSUMER TELE-
1
VISION ADVERTISEMENTS FOR PRESCRIP-
2
TION DRUGS AND BIOLOGICAL PRODUCTS IN-
3
CLUDE LIST PRICE OF SUCH DRUGS AND 
4
PRODUCTS. 
5
Part A of title XI of the Social Security Act (42 
6
U.S.C. 1301 et seq.) is amended by adding at the end 
7
the following new section: 
8
‘‘SEC. 1150C. REQUIREMENT THAT DIRECT-TO-CONSUMER 
9
TELEVISION 
ADVERTISEMENTS 
FOR 
PRE-
10
SCRIPTION DRUGS AND BIOLOGICAL PROD-
11
UCTS INCLUDE LIST PRICE OF SUCH DRUGS 
12
AND PRODUCTS. 
13
‘‘(a) IN GENERAL.—Subject to subsection (b), the 
14
Secretary, acting through the Administrator of the Cen-
15
ters for Medicare & Medicaid Services (referred to in this 
16
section as the ‘Secretary’), shall require that each direct- 
17
to-consumer advertisement on television (including broad-
18
cast, cable, streaming, or satellite media) for a prescrip-
19
tion drug or biological product for which payment is made 
20
available under title XVIII or XIX includes a written 
21
statement indicating the current list price for a 30-day 
22
supply of (or, if determined more appropriate by the Sec-
23
retary, a typical course of treatment with) such drug or 
24
product as follows: ‘The list price for a ø30-day supply 
25
of/typical course of treatment with¿øname of prescription 
26
22:38 Jun 20, 2019
H3327
3 
•HR 3327 IH
drug or biological product¿ is øcurrent list price¿. If you 
1
have health insurance that covers drugs, your cost may 
2
be different.’. Such statement shall be presented at the 
3
end of such an advertisement against a contrasting back-
4
ground for sufficient duration and in a size and style of 
5
font that allows such statement to be read easily. 
6
‘‘(b) EXCEPTION.—The requirement described in 
7
subsection (a) shall not apply with respect to a prescrip-
8
tion drug or biological product that has a current list price 
9
less than $35 per month for a 30-day supply of, or a typ-
10
ical course of treatment with, such drug or product. 
11
‘‘(c) IDENTIFICATION
OF NONCOMPLIANT DRUGS 
12
AND PRODUCTS.—In the case that a direct-to-consumer 
13
advertisement described in subsection (a) does not include 
14
a written statement as required under such subsection and 
15
is not excepted with respect to such statement under sub-
16
section (b), the Secretary shall identify the prescription 
17
drug or biological product that is the subject of such ad-
18
vertisement as a drug or product advertised in violation 
19
of the requirement of subsection (a). The Secretary shall 
20
maintain a public list of all prescription drugs and biologi-
21
cal products identified pursuant to the previous sentence. 
22
‘‘(d) DEFINITIONS.—In this section: 
23
‘‘(1) CURRENT LIST PRICE.—The term ‘current 
24
list price’, with respect to a prescription drug or bio-
25
22:38 Jun 20, 2019
H3327
4 
•HR 3327 IH
logical product described in subsection (a) and a di-
1
rect-to-consumer advertisement described in such 
2
subsection for such drug or product, means the 
3
wholesale acquisition cost (as defined in section 
4
1847A(c)(6)) of such drug or product as of the first 
5
day of the quarter during which such advertisement 
6
is aired or otherwise broadcast. 
7
‘‘(2) TYPICAL COURSE OF TREATMENT.—The 
8
term ‘typical course of treatment’, with respect to a 
9
prescription drug or biological product described in 
10
subsection (a) and a direct-to-consumer advertise-
11
ment described in such subsection for such drug or 
12
product, means the typical course of treatment asso-
13
ciated with the primary indication addressed in such 
14
advertisement for which such drug or product is pre-
15
scribed.’’. 
16
Æ 
22:38 Jun 20, 2019
H3327
